The joint dialogue event is co-hosted by Novartis Access and the Novartis Foundation, with experts from Novartis (No. 2 on the Fair360, formerly DiversityInc Top 50 Companies list), academia and nonprofit organizations speaking and attending.
It will be an opportunity to look back on the lessons learned during the first year of Novartis Access, an innovative social business approach to treat chronic diseases in lower-income countries. Speakers from both Novartis and its partners will present findings and discuss how they addressed challenges in the implementation, one year into the program.
This dialogue will also provide a broader view on how Novartis is working with other organizations to explore innovative approaches to address chronic diseases in lower income countries by both strengthening healthcare systems and improving access to medicines.
